Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tachyphylaxis and bevacizumab.
Ziemssen F, Neuhann IM, Voelker M. Ziemssen F, et al. Ophthalmology. 2009 Aug;116(8):1591-2; author reply 1592-3. doi: 10.1016/j.ophtha.2009.03.038. Ophthalmology. 2009. PMID: 19651319 No abstract available.
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM, Arevalo JF, Fardeau C, Hrisomalos EN, Chan WM, Lai TY, Ziemssen F, Ness T, Sibai AM, Mackensen F, Wolf A, Hrisomalos N, Heiligenhaus A, Spital G, Jo Y, Gomi F, Ikuno Y, Akesbi J, LeHoang P, Adan A, Mahendradas P, Khairallah M, Guthoff R, Ghandour B, Küçükerdönmez C, Kurup SK. Mansour AM, et al. Among authors: ziemssen f. Can J Ophthalmol. 2012 Jun;47(3):269-74. doi: 10.1016/j.jcjo.2012.03.042. Can J Ophthalmol. 2012. PMID: 22687305
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM, Arevalo JF, Ziemssen F, Mehio-Sibai A, Mackensen F, Adan A, Chan WM, Ness T, Banker AS, Dodwell D, Chau Tran TH, Fardeau C, Lehoang P, Mahendradas P, Berrocal M, Tabbarah Z, Hrisomalos N, Hrisomalos F, Al-Salem K, Guthoff R. Mansour AM, et al. Among authors: ziemssen f. Am J Ophthalmol. 2009 Aug;148(2):310-316.e2. doi: 10.1016/j.ajo.2009.03.023. Epub 2009 May 9. Am J Ophthalmol. 2009. PMID: 19427992
Intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M. Mansour AM, et al. Among authors: ziemssen f. Am J Ophthalmol. 2008 Sep;146(3):410-416. doi: 10.1016/j.ajo.2008.05.024. Epub 2008 Jul 10. Am J Ophthalmol. 2008. PMID: 18619571
Bevacizumab: off-label use in ophthalmology.
Grisanti S, Ziemssen F. Grisanti S, et al. Among authors: ziemssen f. Indian J Ophthalmol. 2007 Nov-Dec;55(6):417-20. doi: 10.4103/0301-4738.36474. Indian J Ophthalmol. 2007. PMID: 17951896 Free PMC article. Review.
Penetration of bevacizumab through the retina after intravitreal injection in the monkey.
Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U; Tübingen Bevacizumab Study Group. Heiduschka P, et al. Among authors: ziemssen f. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2814-23. doi: 10.1167/iovs.06-1171. Invest Ophthalmol Vis Sci. 2007. PMID: 17525217
195 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page